
TestCard
UK domiciled startup revolutionizing the direct to consumer healthcare diagnostics market.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Grant | |
Total Funding | 000k |
USD | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 296 % | 124 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
TestCard is a pioneering company in the healthcare sector, specializing in at-home and clinical testing solutions. The company partners with organizations like Yorkshire Cancer Research to deliver technological solutions that provide instant, objective test results and data records. TestCard's core product is the ClearScreen app, which runs on camera-enabled devices, making accurate testing more accessible and affordable globally. The company serves a diverse range of clients, including individual consumers, clinical settings, and pharmacies, aiming to make healthcare testing more accessible and efficient. TestCard operates in the digital health market, focusing on self-testing and pre-procedure screening. The business model revolves around selling affordable test kits and leveraging digital technology to provide fast and accurate medical results. This approach not only improves speed to treatment but also ensures convenience and privacy for users. TestCard generates revenue through the sale of its test kits and partnerships with healthcare organizations.
Keywords: at-home testing, clinical trials, digital health, ClearScreen app, affordable test kits, instant results, healthcare accessibility, pre-procedure screening, technological solutions, medical data records.